Vol. 7, Issue 2, Part A (2025)

Background: Telemedicine has progressed at a fast pace, and healthcare delivery outside of physicians to the patient's extremities is now possible for cases of retina disease. Eye specialists realized more access for dealing with cases in a timely fashion by diagnosing and treating them using telemedicine. Less information is documented regarding the efficacy and patient satisfaction realized using telemedicine for retina disease cases.
Objective: Since the study undergoes a 12-month follow-up, it will evaluate the telemedicine function in patient advancement for pathologies diagnosed with retinal disorders.
Methods: There was a cross-sectional study conducted on eighty patients with various retinal diseases from hospitals in Baghdad, Iraq, between July 2024 and July 2025. The duration of follow-up was 12 months, during which the demographic features, diagnostic outcome, compliance with treatment, and patient satisfaction with telemedicine consultations were assessed by using structured questionnaires.
Results: These patients were of working age (18-55) years. Most patients attained improved visual acuity, wherein 56.25% of them reported remarkable improvement following the telemedicine treatment, and 62.5% follow-up on compliance; patient satisfaction was very high, though, with 81.25% of patients being satisfied or better.
Conclusion: Telemedicine is an effective modality of management and diagnosis of retinal disease. The trial reveals some favorable effects on patient outcomes, patients' compliance with therapy, and patient satisfaction. Because there are satisfactory outcomes, we justify further research in the long-term consequences and the long-term impact of telemedicine in eye care.